Innocoll: Innocoll, DURECT launch Posimir in US to treat postsurgical pain following arthroscopic subacromial decompression surgery
Innocoll Pharmaceuticals Limited, a commercial─stage biotechnology company and portfolio business of Gurnet Point Capital, and DURECT Corporation announced the recent commercial launch of Posimir
Read full article »
Innocoll is a New Jersey-based biotech pharmaceutical company that researches and develops collagen-infused medicinal products for postsurgical pain management.
Read more